Risperidone: A New, Novel (and Better?) Antipsychotic
- 1 February 1996
- journal article
- Published by SLACK, Inc. in Psychiatric Annals
- Vol. 26 (2) , 78-87
- https://doi.org/10.3928/0048-5713-19960201-08
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Critique of the Canadian Multicenter Placebo-Controlled Study of Risperidone and HaloperidolJournal of Clinical Psychopharmacology, 1995
- Risperidone Augmentation of ClozapinePharmacopsychiatry, 1995
- Risperidone for Tourette's syndromeThe Lancet, 1994
- Neuroleptic malignant syndrome associated with the use of risperidone, an atypical antipsychotic agentHuman Psychopharmacology: Clinical and Experimental, 1994
- Risperidone for hallucinations in levodopa-treated Parkinson's disease patientsThe Lancet, 1994
- Serotonin‐dopamine antagonist and Gilles de la tourette's syndrome: An open pilot dose‐titration study with risperidoneMovement Disorders, 1994
- Risperidone in the Treatment of Disorders with a combined Psychotic and Depressive Syndrome - A Functional ApproachPharmacopsychiatry, 1992
- Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative studyActa Psychiatrica Scandinavica, 1992
- Long-term treatment of chronic schizophrenia patients with risperidoneSchizophrenia Research, 1990
- Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patientsPsychopharmacology, 1989